LeonaBio (LONA) Assets (2019 - 2026)

LeonaBio (LONA) has 8 years of Assets data on file, last reported at $71.6 million in Q1 2026.

• Assets for Q1 2026 came in at $71.6 million, up 64.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.6 million (up 64.53% YoY), and the FY2025 annual result was $92.2 million, up 56.78% from the prior year.
• Assets eased to $71.6 million in Q1 2026 per LONA's latest filing, from $92.2 million in the prior quarter.
• Over five years, Assets peaked at $313.0 million in Q1 2022 and troughed at $30.0 million in Q3 2025.
• A 5-year average of $152.1 million and a median of $133.5 million in 2024 frame the typical range for Assets.
• The sharpest annual moves came in 2025 and 2026: Assets plunged 68.05% in 2025, then soared 64.53% in 2026.
• A 5-year view of Assets shows it stood at $258.2 million in 2022, then sank by 37.93% to $160.2 million in 2023, then plunged by 63.32% to $58.8 million in 2024, then soared by 56.78% to $92.2 million in 2025, then dropped by 22.31% to $71.6 million in 2026.
• Business Quant data shows LONA's Assets at $71.6 million in Q1 2026, $92.2 million in Q4 2025, and $30.0 million in Q3 2025.